BlackRock Group’s Globus Medical GMED Stock Holding History

BlackRock Group’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.24M	Buy	49,883 +2,854	+6%	+$64.9K	﹤0.01%	2027
2016 Q3	$1.06M	Sell	47,029 -900	-2%	-$21.2K	﹤0.01%	2004
2016 Q2	$1.14M	Sell	47,929 -408	-0.8%	-$9.79K	﹤0.01%	1904
2016 Q1	$1.15M	Buy	48,337 +9,205	+24%	+$225K	﹤0.01%	1870
2015 Q4	$1.09M	Buy	39,132 +5,521	+16%	+$139K	﹤0.01%	1847
2015 Q3	$694K	Buy	33,611 +14,019	+72%	+$355K	﹤0.01%	2073
2015 Q2	$503K	Buy	19,592 +11,928	+156%	+$302K	﹤0.01%	2261
2015 Q1	$194K	Buy	7,664 +1,258	+20%	+$30.6K	﹤0.01%	2504
2014 Q4	$153K	Buy	6,406 +3,429	+115%	+$75.9K	﹤0.01%	2583
2014 Q3	$58K	Hold	2,977	–	–	﹤0.01%	2666
2014 Q2	$72K	Hold	2,977	–	–	﹤0.01%	2648
2014 Q1	$79K	Sell	2,977 -1,565	-34%	-$37.2K	﹤0.01%	2595
2013 Q4	$92K	Buy	4,542 +2,363	+108%	+$43.9K	﹤0.01%	2495
2013 Q3	$38K	Hold	2,179	–	–	﹤0.01%	2746
2013 Q2	$37K	Buy	+2,179	New	+$33.6K	﹤0.01%	2475

Other funds holding GMED

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AAM

Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return

BlackRock Group's GMED Position: Q4 2016 in Review

BlackRock Group increased its Globus Medical (GMED) stake by 6.1% in Q4 2016, buying an estimated $64.9K and bringing the position to 49,883 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #2027.

BlackRock Group first reported a position in GMED in Q2 2013 and has held it in 15 quarters since. 207 funds tracked by Wall St. Rank hold GMED as of Q4 2016.

BlackRock Group held 49,883 shares of Globus Medical worth $1.24M as of Q4 2016.
BlackRock Group bought 2,854 Globus Medical shares in Q4 2016, an estimated $64.9K.
Globus Medical made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2027 holding.
BlackRock Group first reported a position in Globus Medical in Q2 2013 and has held it in 15 quarters since.
207 funds tracked by Wall St. Rank held Globus Medical as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.